AGREEMENTAsset Purchase Agreement • December 7th, 2012 • MEI Pharma, Inc. • Pharmaceutical preparations • New York
This Agreement (this “Agreement”), dated as of December 5, 2012, is entered into by MEI Pharma, Inc. (formerly known as Marshall Edwards, Inc.), a Delaware corporation (“MEIP”), Novogen Limited, a public company limited by shares and incorporated under the laws of New South Wales, Australia (“Seller Parent”), Novogen Research Pty Limited, a proprietary limited company incorporated under the laws of Australia and a wholly-owned subsidiary of Seller Parent (“Seller” and together with Seller Parent, the “Novogen Parties” and each, a “Novogen Party”) and Graham Kelly, an individual, and Andrew Heaton, an individual, for purposes of Section 4.2 and Articles VII and VIII, only.
